Micro-Needle & Needless Injection System

CHECK FOR AVAILABILITY - Available IP Portfolios
ID ICAP-010
Seller Valeritas Holdings, Inc.
Sector Drug Delivery
Assets 38 Assets: 20 US Patents, 13 Foreign Patents, 5 Applications
US Patents 6,314,317 6,406,455 6,490,483 6,616,627 6,960,184 7,027,478 7,150,409 7,187,969 7,740,607 7,806,867 7,931,614 8,361,037 8,500,681 8,540,672 8,734,395 8,920,375 9,011,392 9,155,875 9,415,198 9,561,042
Other Patents AU2006278258; AU2012203204; CA2430499; CA2659785; EP1296730; EP1339442; EP1161277; EP1590034; EP2654582; JP5525020; EP1144031; JP6082697; JP6093571
Applications JP2015-180278; JP2016-52583; CA2817035; EP1924209; EP2514374

Lot Summary

With priority dates from 1998 to 2010, the disclosed portfolio includes two families. The first family
is based around a needless injection system, allowing for the transfer of a liquid drug via the needless
injection system. The second family is focused on a low cost micro-needle technology; specifically a
microneedle with an integrated reservoir as well as an applicator system for a microneedle patch.

The needless injection technology would be appropriate for companies interested in the delivery of a
liquid or reconstituted injectable pharmaceutical. The microneedle technology would be of interest to
companies interested in the transdermal delivery of low volumes of dried pharmaceuticals.
Additionally, limited sample components for the micro-needle technology can be provided to
interested parties.

Due Diligence

Patent NumberFile History
6,314,317
6,406,455
6,490,483
6,616,627
6,960,184fh6960184.pdf
7,027,478fh7027478.pdf
7,150,409fh7150409.pdf
7,187,969fh7187969.pdf
7,740,607fh7740607.pdf
7,806,867fh7806867.pdf
7,931,614fh7931614.pdf
8,361,037fh8361037.pdf
8,500,681fh8500681.pdf
8,540,672fh8540672.pdf
8,734,395fh8734395.pdf
8,920,375fh8920375.pdf
9,011,392fh9011392.pdf
9,155,875fh9155875.pdf
9,415,198fh9415198.pdf
9,561,042fh9561042.pdf